title: Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.
authors.forename: Ninon
authors.initials: N
authors.lastname: Taylor
authors.forename: Thomas
authors.initials: T
authors.lastname: Melchardt
authors.forename: Michael
authors.initials: M
authors.lastname: Grundbichler
authors.forename: Michael
authors.initials: M
authors.lastname: Strasser
authors.forename: Alexander
authors.initials: A
authors.lastname: Egle
authors.forename: Richard
authors.initials: R
authors.lastname: Greil
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D010976:Platelet Count; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D013926:Thrombopoietin / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D013926:Thrombopoietin; C488777:romiplostim; C100416:peginterferon alfa-2a